Eosinophil cationic protein's role in human hepatic allograft rejection
- PMID: 1711002
Eosinophil cationic protein's role in human hepatic allograft rejection
Abstract
Although it is known that eosinophils consistently infiltrate rejecting human liver allografts, their function is unknown. Infiltrating eosinophils can release a cytotoxic substance, eosinophil cationic protein. Furthermore, eosinophil cationic protein may be identified in biopsy specimens using immunoperoxidase staining of an eosinophil cationic protein-specific monoclonal antibody. To study a possible effector role of eosinophils in rejecting liver allografts, 38 serial allograft biopsy specimens from 12 patients with acute rejection, 54 biopsy specimens from 11 patients with allograft dysfunction caused by other causes and 22 biopsy specimens from 8 patients without allograft dysfunction were stained for extracellular eosinophil cationic protein. In addition, the absolute blood eosinophil counts and the portal tract eosinophil percent of the total number of portal tract inflammatory cells were tabulated in these patients until 30 days after transplantation. The blood absolute eosinophil count, portal tract eosinophil percent and incidence of positive extracellular eosinophil cationic protein staining were significantly increased in patients with rejection compared with patients with dysfunction from other causes (p less than 0.05 to 0.005, t test). Furthermore, each of these parameters predicted rejection with excellent sensitivity (75% to 92%) and specificity (91% to 100%). Of patients with rejection, 59% had significant elevation of all three parameters before or during rejection, and 92% had at least two parameters elevated. Conversely, of the patients with dysfunction from other causes, 0% had elevations of any parameter. The recognized cytotoxic properties of eosinophil cationic protein and its almost exclusive presence, along with eosinophils in the blood and allograft biopsy specimens of patients during acute rejection, support the role of the eosinophil as an effector cell in tissue injury during acute liver allograft rejection.
Similar articles
-
The eosinophil as an effector cell of the immune response during hepatic allograft rejection.Hepatology. 1994 Sep;20(3):654-62. doi: 10.1016/0270-9139(94)90102-3. Hepatology. 1994. PMID: 7521317
-
Association between blood eosinophil counts and acute cardiac and pulmonary allograft rejection.J Heart Lung Transplant. 1998 May;17(5):517-24. J Heart Lung Transplant. 1998. PMID: 9628572
-
Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis.Am J Gastroenterol. 1997 Dec;92(12):2245-9. Am J Gastroenterol. 1997. PMID: 9399763
-
Role of liver allograft biopsy in patient management.Semin Liver Dis. 1992 Feb;12(1):60-72. doi: 10.1055/s-2007-1007377. Semin Liver Dis. 1992. PMID: 1570552 Review.
-
Eosinophils in acute cellular rejection in liver allografts.Liver Transpl Surg. 1998 Sep;4(5):355-62. doi: 10.1002/lt.500040503. Liver Transpl Surg. 1998. PMID: 9724472 Review.
Cited by
-
Critical roles for IL-4, IL-5, and eosinophils in chronic skin allograft rejection.J Clin Invest. 1999 Jun;103(12):1659-67. doi: 10.1172/JCI5504. J Clin Invest. 1999. PMID: 10377172 Free PMC article.
-
Three cases of primary biliary cirrhosis associated with bronchial asthma.J Gastroenterol. 1995 Oct;30(5):667-71. doi: 10.1007/BF02367796. J Gastroenterol. 1995. PMID: 8574342
-
Innate immune cells in liver inflammation.Mediators Inflamm. 2012;2012:949157. doi: 10.1155/2012/949157. Epub 2012 Aug 9. Mediators Inflamm. 2012. PMID: 22933833 Free PMC article. Review.
-
Primary sclerosing cholangitis with marked eosinophilic infiltration in the liver.J Gastroenterol. 1995 Aug;30(4):524-8. doi: 10.1007/BF02347572. J Gastroenterol. 1995. PMID: 7550866
-
A comparison of organ cultured fetal pancreas allo-, iso-, and xenografts (pig) in non-immunosuppressed non-obese diabetic mice.Am J Pathol. 1995 Sep;147(3):834-44. Am J Pathol. 1995. PMID: 7677195 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical